Nature Communications (Apr 2024)

CoPoP liposomes displaying stabilized clade C HIV-1 Env elicit tier 2 multiclade neutralization in rabbits

  • Annemart Koornneef,
  • Kanika Vanshylla,
  • Gijs Hardenberg,
  • Lucy Rutten,
  • Nika M. Strokappe,
  • Jeroen Tolboom,
  • Jessica Vreugdenhil,
  • Karin Feddes-de Boer,
  • Aditya Perkasa,
  • Sven Blokland,
  • Judith A. Burger,
  • Wei-Chiao Huang,
  • Jonathan F. Lovell,
  • Danielle van Manen,
  • Rogier W. Sanders,
  • Roland C. Zahn,
  • Hanneke Schuitemaker,
  • Johannes P. M. Langedijk,
  • Frank Wegmann

DOI
https://doi.org/10.1038/s41467-024-47492-1
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 16

Abstract

Read online

Abstract One of the strategies towards an effective HIV-1 vaccine is to elicit broadly neutralizing antibody responses that target the high HIV-1 Env diversity. Here, we present an HIV-1 vaccine candidate that consists of cobalt porphyrin-phospholipid (CoPoP) liposomes decorated with repaired and stabilized clade C HIV-1 Env trimers in a prefusion conformation. These particles exhibit high HIV-1 Env trimer decoration, serum stability and bind broadly neutralizing antibodies. Three sequential immunizations of female rabbits with CoPoP liposomes displaying a different clade C HIV-1 gp140 trimer at each dosing generate high HIV-1 Env-specific antibody responses. Additionally, serum neutralization is detectable against 18 of 20 multiclade tier 2 HIV-1 strains. Furthermore, the peak antibody titers induced by CoPoP liposomes can be recalled by subsequent heterologous immunization with Ad26-encoded membrane-bound stabilized Env antigens. Hence, a CoPoP liposome-based HIV-1 vaccine that can generate cross-clade neutralizing antibody immunity could potentially be a component of an efficacious HIV-1 vaccine.